Loading clinical trials...
Loading clinical trials...
COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF
Conditions
Locations
11
United Kingdom
University Hospital Southampton Nhs Foundation Trust
Southampton, Engladn, United Kingdom
University Hospitals Birmingham Nhs Foundation Trust
Birmingham, England, United Kingdom
Birmingham Women'S and Children'S Nhs Foundation Trust
Birmingham, England, United Kingdom
Leeds Teaching Hospitals Nhs Trust
Leeds, England, United Kingdom
King'S College Hospital Nhs Foundation Trust
London, England, United Kingdom
Royal Brompton & Harefield Nhs Foundation Trust
London, England, United Kingdom
Start Date
November 19, 2021
Primary Completion Date
May 1, 2024
Completion Date
May 1, 2024
Last Updated
February 1, 2022
NCT02417740
NCT06616857
NCT02740868
NCT07108153
NCT07303621
NCT07274631
Lead Sponsor
Queen's University, Belfast
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions